$ATS

ATS Non-GAAP EPS of $0.27 beats by $0.04, revenue of $665.8M beats by $181.92M (ATS:NYSE)

ATS reported Q2 Non-GAAP EPS of $0.27, exceeding estimates by $0.04. Revenue was $665.8M, down 8.6% year-over-year but beating expectations by $181.92M. Order bookings rose to $827M from $734M a year ago, while the order backlog slightly decreased to $2,009M from $2,070M.

Original reporting
Published Nov 4, 2026, 11:07 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ATS
Bullish
high confidence
Mentioned
$ATS
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$ATSBullishMed
01

Why it matters

The earnings beat could trigger short-term buying interest, especially from momentum traders.

02

Market read

Earnings surprise provides a fresh trading catalyst for ATS and potentially its sector peers.

03

What to watch

Guidance outlook and cash flow details were not disclosed.

Relevance 7/10Novelty 8/10Timing: post-market today

Background

ATS (NYSE:ATS) is a small-cap industrial automation company releasing its Q2 earnings.

Company-level read

Ticker impact

$ATSBullishHigh confidence
Context

ATS reported Q2 Non-GAAP EPS of $0.27 beating expectations by $0.04 and revenue of $665.8M beating by $181.92M.

Expected impact

likely upside as market prices in the earnings beat

Evidence & confidence

Both EPS and revenue exceeded expectations, a typical catalyst for short-term rally.

Market effects

Positive surprise may lift peer industrial automation stocks.

Minor impact on US small-cap segment.

Limited to US equity markets.

Counterpoint

If the beat is already priced in, the stock could face a pullback.

Key entities

  • ATS

    Industrial automation firm reporting Q2 results.

Related articles

$ATSHigh

ATS Corporation reports Q2 earnings miss, cuts guidance

ATS Corporation (TSX:ATS, NYSE:ATS) reported Q2 fiscal 2027 earnings below expectations, with adjusted EPS of $0.27 and revenue of $665.8 million, down 8.6% YoY. The company withdrew its full-year guidance, citing delays in non-life sciences businesses and tariff impacts. Q3 revenue is expected to be $640M-$680M. Order Bookings rose 12.7% YoY to $827M, led by life sciences.

$ATSMedAI 8/10

ATS (ATS) Q1 2027 Earnings Call Transcript

ATS Corporation reported Q1 fiscal 2027 results on Aug. 6, 2026. Adjusted revenue was $698 million, down 5% y/y, and adjusted EPS was $0.35. Adjusted earnings from operations fell 13.4% to $68.1 million. Order backlog was $1.9 billion and Q2 revenue guidance was $660 million to $700 million. ATS also outlined an 18-month transformation program and $70m to $90m capex guidance.

$ATSMed

ATS Q1 Earnings Call Highlights

ATS said it will consolidate some European facilities and shift technical capabilities to sites with capacity. Management expects the first phase to deliver about CAD 20 million in annualized savings, about 30% of the total fixed-cost program (CAD 60-70 million). Q1 restructuring costs were CAD 5.7 million and non-cash charges CAD 21.5 million. ATS guided Q2 revenue to CAD 660-700 million.

$ATSMed

ATS Reports First Quarter Fiscal 2027 Results and Announces a Fixed Cost Transformation Program

ATS Corporation reported fiscal 2027 first-quarter results for the three months ended June 28, 2026. Revenues were C$693.7 million versus C$736.7 million a year earlier, with a C$0.3 million net loss. Adjusted EBITDA was C$92.9 million. ATS also announced an 18-month Fixed Cost Transformation Program, targeting 15% adjusted earnings from operations margin, with an initial European footprint consolidation and expected C$20 million annual cost reductions.

$ATSMedAI 9/10

ATS (ATS) Q4 2026 Earnings Call Transcript

ATS reported Q4 2026 adjusted revenues of $744 million (+3.2%); organic growth was 1.5% with a 1.7% FX benefit. Q4 adjusted earnings from operations rose 3.4% to $76.8 million; gross margin was 29.4%. Order bookings were $704 million (-18.4%) and backlog about $2 billion. Fiscal 2027 guidance calls for Q1 revenues $700–$740 million and modest full-year growth, with margin improving 50–75 bps.